![]() |
市場調查報告書
商品編碼
1784625
2021-2031年亞太地區雷射輔助耳鼻喉手術市場報告(範圍、細分、動態和競爭分析)Asia Pacific Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
亞太地區雷射輔助耳鼻喉手術市場規模預計將從 2023 年的 49,406.24 千美元增至 2031 年的 1,17,988.30 千美元。預計 2023 年至 2031 年期間該市場的複合年成長率為 11.5%。
執行摘要和亞太地區雷射輔助耳鼻喉手術市場分析:
雷射輔助耳鼻喉手術在日本獲得了顯著發展,體現了該國致力於將先進醫療技術融入醫療保健領域的決心。保澤耳鼻喉診所是專門進行內視鏡雷射手術的機構之一,該手術針對喉癌、中耳疾病以及導致聲音品質下降的喉部缺陷等疾病。該診所的院長被譽為日本最優秀的醫生之一,他強調雷射技術在提高手術精準度和病人安全方面的重要性。日本的研究和臨床研究持續驗證雷射輔助耳鼻喉手術的有效性。東京醫科大學積極推動雷射技術在耳鼻喉應用領域的研發。該大學與多家醫院合作進行臨床研究,以驗證雷射輔助手術的有效性。這種合作增強了雷射技術的實際應用,並豐富了該領域的整體知識體系。這些研究有助於提供更多證據,支持雷射在各種應用中的應用,從治療慢性鼻竇炎到對聲帶進行精細的手術。這些研究報告的積極成果提高了雷射技術的可信度,鼓勵更多的從業人員在實踐中採用這些技術。
亞太地區雷射輔助耳鼻喉手術市場細分分析:
有助於得出雷射輔助耳鼻喉手術市場分析的關鍵部分是雷射類型、手術類型和最終用戶。
根據雷射類型,雷射輔助耳鼻喉手術市場細分為二氧化碳雷射、Nd.YAG雷射、二極體雷射、藍光雷射、KTP雷射、氬雷射和其他雷射類型。二氧化碳雷射在2023年佔據了最大的市場佔有率。
就手術類型而言,雷射輔助耳鼻喉手術市場分為雷射喉部手術、雷射內視鏡鼻竇手術 (LESS)、雷射輔助懸雍垂腭咽成形術 (LAUP)、雷射輔助鐙骨切開術、雷射輔助扁桃體切除術和腺樣體切除術、雷射鼻甲縮小手術、經口雷射顯微手術 (TLM)、鼻腔手術 (TLM)、鼻內手術類型。 2023 年,雷射輔助扁桃體切除術和腺樣體切除術佔據了最大的市場佔有率。
根據最終用戶,雷射輔助耳鼻喉手術市場可分為醫院和專科診所、醫生辦公室和其他最終用戶。醫院和專科診所在2023年佔據了最大的市場。
亞太地區雷射輔助耳鼻喉手術市場展望
隨著醫療技術的進步,醫護人員和患者越來越傾向於選擇能夠最大程度減少創傷、縮短恢復時間並改善療效的手術方案。這種轉變在耳鼻喉科手術中尤其明顯,傳統的侵入性技術正被精準高效的先進雷射輔助方法所取代。 RAPIDO ENT BLUE 是一款獨特的攜帶式雷射系統,旨在滿足各種臨床應用的需求,提供接觸式和非接觸式治療方案。其便攜性和多功能性使其成為希望在無需大量基礎設施的情況下擴展手術能力的醫護人員的理想之選。
微創手術切口較小甚至無切口,顯著降低併發症風險,最大程度減輕術後疼痛,並縮短住院時間。雷射技術的精準性使外科醫生能夠精準定位特定組織,而不會影響周圍區域,這對於涉及咽喉和鼻腔的精細手術至關重要。這種精準度的提升不僅能改善手術效果,還能促進患者更快康復,讓患者能更快恢復日常生活。
微創手術需求的不斷成長,主要源自於患者對疼痛較小、更有效率治療方案的偏好。患者對微創手術的了解程度更高,並積極尋求符合其快速康復和最大程度減少生活方式干擾的替代方案。隨著人們對雷射輔助技術益處的認知不斷提高,預計會有更多患者尋求此類治療,從而增加雷射輔助耳鼻喉手術的整體需求。醫療保健提供者意識到這一趨勢,正在投資先進的雷射技術,以滿足患者需求並保持市場競爭力。
因此,微創手術的日益普及正在重塑雷射輔助耳鼻喉手術市場,為成長和創新提供了巨大的機會。隨著利害關係人持續投資於這個不斷發展的領域,雷射輔助耳鼻喉手術的未來前景光明,有望為全球患者提供更優質的照護和更高品質的生活。
亞太地區雷射輔助耳鼻喉手術市場國家洞察
按國家/地區分類,亞太地區雷射輔助耳鼻喉手術市場包括中國、日本、印度、澳洲、韓國和亞太其他地區。中國在2023年佔最大佔有率。
隨著醫療技術的進步以及對微創手術方案的需求不斷成長,中國的雷射輔助耳鼻喉手術數量顯著增加。這種創新方法利用各種雷射器,例如二氧化碳雷射器和釹釔鋁石榴石雷射器,對耳、鼻、喉問題進行精準的手術治療,從而改善患者的治療效果並縮短康復時間。根據《耳鼻喉與放射學新聞》報道,與西方國家類似,經口雷射顯微手術已在中國各頭頸治療中心廣泛應用於治療早期喉癌。
北京、上海、廣州等大城市的醫院都已投資先進的雷射技術,使外科醫生能夠更精準地執行複雜的手術,並減少對周圍組織的傷害。這種精準度在喉部和鼻腔等敏感部位尤其有效,而傳統的手術方法在這些部位併發症風險更高。 2023年12月,復旦大學附屬眼耳鼻喉科醫院浦江院區二期工程在閔行區農村地區開工建設,計劃在現有350張床位的基礎上再增加150張床位。中國政府鼓勵將先進技術融入醫療實踐,從而推廣雷射輔助手術的應用。政府也支持實施外科醫生培訓項目,使他們能夠掌握有效運用雷射技術的必要技能。因此,許多耳鼻喉專科醫生都精通雷射技術。
亞太地區雷射輔助耳鼻喉手術市場公司概況
市場上的一些主要參與者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight這些參與者正在採用擴張、產品創新和併購等各種策略,為消費者提供創新產品並增加市場佔有率。
亞太地區雷射輔助耳鼻喉手術市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The Asia Pacific Laser-Assisted ENT Surgery Market size is expected to reach US$ 1,17,988.30 thousand by 2031 from US$ 49,406.24 thousand in 2023. The market is estimated to record a CAGR of 11.5% from 2023 to 2031.
Executive Summary and Asia Pacific Laser-Assisted ENT Surgery Market Analysis:
Laser-assisted ENT surgeries have gained significant traction in Japan, reflecting the country's commitment to integrating advanced medical technologies into healthcare. Hozawa ENT Clinic is one of the facilities specializing in endoscopic laser surgeries for conditions such as laryngeal cancer, middle ear disorders, and laryngeal defects leading to voice quality degradation. The clinic's director, recognized as one of Japan's best doctors, emphasizes the importance of laser techniques in improving surgical precision and patient safety. Research and clinical studies in Japan continue to validate the effectiveness of laser-assisted ENT surgeries. Tokyo Medical University has proactively promoted research and development in laser technologies for ENT applications. The university collaborates with various hospitals to conduct clinical studies validating laser-assisted procedures' effectiveness. This collaboration enhances the practical application of laser technology and contributes to the overall body of knowledge in the field. Such studies contribute to an expanding pool of evidence supporting the use of lasers in various applications, from treating chronic sinusitis to performing delicate surgeries on the vocal cords. The positive outcomes reported in these studies enhance the credibility of laser techniques, encouraging more practitioners to adopt them in their practices.
Asia Pacific Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2laser, Nd.YAGlaser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (LESS), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
Asia Pacific Laser-Assisted ENT Surgery Market Outlook
As medical technology advances, healthcare providers and patients increasingly lean toward surgical options that minimize trauma, reduce recovery time, and enhance patient outcome. This shift is particularly evident in ENT surgery, where traditional invasive techniques are being replaced by state-of-the-art laser-assisted methods that offer precision and efficiency. RAPIDO ENT BLUE is a unique portable laser system designed to meet various clinical applications' demands, offering contact and non-contact treatment options. Its portability and versatility make it an attractive choice for healthcare providers looking to expand their surgical capabilities without requiring extensive infrastructure.
Minimally invasive procedures utilize smaller or no incisions, significantly decreasing the risk of complications, minimizing postoperative pain, and shortening hospital stays. The precision of laser technology allows surgeons to target specific tissues without affecting surrounding areas, which is crucial in delicate procedures involving the throat and nasal passages. This enhanced accuracy improves surgical outcomes and fosters quicker recoveries, enabling patients to return to their daily activities sooner.
The rising demand for minimally invasive procedures is primarily driven by patient preferences for less painful and more efficient treatment options. Patients are more informed and actively seek alternatives that align with their desire for quick recovery and minimal lifestyle disruption. As awareness of the benefits of laser-assisted techniques spreads, more patients are expected to request these options, increasing the overall demand for laser-assisted ENT surgeries. Healthcare providers, recognizing this trend, are investing in advanced laser technologies to meet patient needs and remain competitive within the market.
As a result, the increasing adoption of minimally invasive procedures is reshaping the laser-assisted ENT surgery market, providing numerous opportunities for growth and innovation. As stakeholders continue to invest in this evolving landscape, the future of laser-assisted ENT surgery looks promising, with the potential to deliver enhanced care and improved quality of life for patients worldwide.
Asia Pacific Laser-Assisted ENT Surgery Market Country Insights
Based on country, the Asia Pacific laser-assisted ENT surgery market comprises China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share in 2023.
The number of laser-assisted ENT surgeries has increased significantly in China due to advancements in medical technology and an increasing demand for minimally invasive surgical options. This innovative approach utilizes various lasers, such as CO2 and neodymium YAG lasers, to perform precise surgical procedures for the treatment of ear, nose, and throat issues, enhancing patient outcomes and reducing recovery times. According to ENT and Radiology News, similar to Western countries, transoral laser microsurgeries for early laryngeal cancer has been adopted widely at different head and neck treatment centers in China.
Hospitals across major cities such as Beijing, Shanghai, and Guangzhou have invested in state-of-the-art laser technology, allowing surgeons to perform complex procedures with greater accuracy and less trauma to surrounding tissues. This precision is particularly beneficial in delicate areas such as the larynx and nasal passages, where traditional surgical methods may pose higher risks of complications. In December 2023, construction started on the second phase of the Pujiang branch of Fudan University's eye, ear, nose, and throat hospital in the rural region of Minhang District; the plan involves the addition of another 150 beds to the existing capacity of 350. The Chinese government promotes the adoption of laser-assisted surgeries by encouraging the integration of advanced technologies in medical practice. It also provides support for the implementation of training programs for surgeons, enabling them to acquire the necessary skills to utilize laser technology effectively. As a result, many ENT specialists are proficient in laser techniques.
Asia Pacific Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Asia Pacific Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise